NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy Status COMPLETED Phase PHASE3
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00595413 Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II) Status COMPLETED Phase PHASE2
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment Status COMPLETED Phase PHASE3
NCT00573794 Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy Status COMPLETED Phase PHASE3
NCT00550446 A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00525902 Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Status COMPLETED Phase PHASE2
NCT00517296 Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas Status COMPLETED Phase PHASE4
NCT00514982 Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome Status WITHDRAWN Phase PHASE2
NCT00497614 Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA) Status COMPLETED Phase NA
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease Status COMPLETED Phase PHASE2/PHASE3